BR112016022439A2 - Composições farmacêuticas que compreendem cefepima ou sulbactama - Google Patents
Composições farmacêuticas que compreendem cefepima ou sulbactamaInfo
- Publication number
- BR112016022439A2 BR112016022439A2 BR112016022439A BR112016022439A BR112016022439A2 BR 112016022439 A2 BR112016022439 A2 BR 112016022439A2 BR 112016022439 A BR112016022439 A BR 112016022439A BR 112016022439 A BR112016022439 A BR 112016022439A BR 112016022439 A2 BR112016022439 A2 BR 112016022439A2
- Authority
- BR
- Brazil
- Prior art keywords
- sulbactam
- pharmaceutical compositions
- cefepim
- pharmaceutically acceptable
- acceptable derivative
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 title abstract 3
- 229960005256 sulbactam Drugs 0.000 title abstract 3
- -1 beta-lactam compound Chemical class 0.000 abstract 1
- HVFLCNVBZFFHBT-ZKDACBOMSA-N cefepime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 HVFLCNVBZFFHBT-ZKDACBOMSA-N 0.000 abstract 1
- 229960002100 cefepime Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1194MU2014 IN2014MU01194A (https=) | 2014-03-29 | 2015-01-14 | |
| PCT/IB2015/050268 WO2015150926A1 (en) | 2014-03-29 | 2015-01-14 | Pharmaceutical compositions comprising cefepime or sulbactam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016022439A2 true BR112016022439A2 (pt) | 2017-08-15 |
Family
ID=54239460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016022439A BR112016022439A2 (pt) | 2014-03-29 | 2015-01-14 | Composições farmacêuticas que compreendem cefepima ou sulbactama |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20170151221A1 (https=) |
| EP (1) | EP3125887A1 (https=) |
| JP (1) | JP2017508769A (https=) |
| KR (1) | KR20160130824A (https=) |
| CN (1) | CN106900171A (https=) |
| BR (1) | BR112016022439A2 (https=) |
| IN (1) | IN2014MU01194A (https=) |
| MX (1) | MX2016012646A (https=) |
| WO (1) | WO2015150926A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4146650B1 (en) * | 2020-09-01 | 2026-01-21 | Ningxia Academy of Agriculture and Forestry Sciences | Beta-lactamase inhibitors and their preparation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE476981T1 (de) * | 2004-12-02 | 2010-08-15 | Venus Remedies Ltd | Zusammensetzungen zur bekämpfung von beta- lactamase-vermittelter antibiotischer resistenz mittels beta-lactamase-hemmern für injektionen |
| PT2714034T (pt) * | 2011-05-28 | 2018-10-30 | Wockhardt Ltd | Composições que compreendem cefepime e tazobactam |
| EP2768503A1 (en) * | 2011-07-26 | 2014-08-27 | Wockhardt Limited | Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor |
| US9744160B2 (en) * | 2011-07-26 | 2017-08-29 | Wockhardt Limited | Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor |
| RU2578370C2 (ru) * | 2011-08-27 | 2016-03-27 | Вокхардт Лимитед | Производные 1,6- диазабицикло [3,2,1] октан-7-она и их применение при лечении бактериальных инфекционных болезней |
| US8796257B2 (en) * | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| BR112015003592B1 (pt) * | 2012-08-25 | 2020-04-14 | Wockhardt Ltd | derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas |
| WO2014141132A1 (en) * | 2013-03-14 | 2014-09-18 | Naeja Pharmaceutical Inc. | NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS |
-
2015
- 2015-01-14 KR KR1020167027684A patent/KR20160130824A/ko not_active Withdrawn
- 2015-01-14 IN IN1194MU2014 patent/IN2014MU01194A/en unknown
- 2015-01-14 EP EP15706531.9A patent/EP3125887A1/en not_active Withdrawn
- 2015-01-14 US US15/300,113 patent/US20170151221A1/en not_active Abandoned
- 2015-01-14 CN CN201580017231.6A patent/CN106900171A/zh active Pending
- 2015-01-14 WO PCT/IB2015/050268 patent/WO2015150926A1/en not_active Ceased
- 2015-01-14 MX MX2016012646A patent/MX2016012646A/es unknown
- 2015-01-14 BR BR112016022439A patent/BR112016022439A2/pt not_active IP Right Cessation
- 2015-01-14 JP JP2016558575A patent/JP2017508769A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20170151221A1 (en) | 2017-06-01 |
| MX2016012646A (es) | 2016-10-28 |
| CN106900171A (zh) | 2017-06-27 |
| JP2017508769A (ja) | 2017-03-30 |
| IN2014MU01194A (https=) | 2015-10-02 |
| EP3125887A1 (en) | 2017-02-08 |
| WO2015150926A1 (en) | 2015-10-08 |
| KR20160130824A (ko) | 2016-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20200122B1 (ar) | مركبات مفيدة لتثبيط cdk7 | |
| BR112018003026A2 (pt) | composições compreendendo um inibidor de pi3k e um inibidor de hdac | |
| TW201613911A (en) | Heterocyclic compounds and uses thereof | |
| PH12016502255A1 (en) | Combination | |
| PH12020551586A1 (en) | Oxysterols and methods of use thereof | |
| BR112016024235A2 (pt) | composições farmacêuticas compreendendo agentes antibacterianos | |
| MX2017014035A (es) | Formas solidas novedosas. | |
| MX376057B (es) | Formulaciones de aripiprazol que tienen mayores velocidades de inyeccion. | |
| BR112018074985A2 (pt) | composições antibacterianas | |
| PH12017502319A1 (en) | Injectable pharmaceutical formulations of lefamulin | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| NZ739518A (en) | Compounds useful for inhibiting ror-gamma-t | |
| TW201613898A (en) | Benzofuran analogue as NS4B inhibitor | |
| MX2017014880A (es) | Composiciones farmaceuticas y uso de las mismas. | |
| IN2014MU00859A (https=) | ||
| IN2013MU03308A (https=) | ||
| BR112016024236A2 (pt) | composições farmacêuticas compreendendo agentes antibacterianos | |
| JOP20190159A1 (ar) | توليفة من مثبط mcl-1 ومركب تاكسان، استخداماتها وتركيباتها الصيدلانية | |
| BR112016022439A2 (pt) | Composições farmacêuticas que compreendem cefepima ou sulbactama | |
| IN2013MU03421A (https=) | ||
| MX375934B (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| IN2013MU03422A (https=) | ||
| MX2018010652A (es) | Composiciones farmaceuticas. | |
| MX2017010992A (es) | Composiciones farmaceuticas estables que comprenden agente antibacteriano. | |
| BR112018070123A2 (pt) | oxiesterós e métodos de uso dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2549 DE 12-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |